biotech · Amyotrophic Lateral Sclerosis (ALS) · Amyotrophic Lateral Sclerosis · BCLI
BRAINSTORM CELL THERAPEUTICS
BRAINSTORM CELL THERAPEUTICS INC.
BRAINSTORM CELL THERAPEUTICS clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
NEW YORK, NY, USA HQ
2004 Founded
30 Employees
Public company Type
BCLI · NYSE Ticker
Company details
- Status
- Public
- HQ
- NEW YORK, NY, USA
- Founded
- 2004
- Employees
- 30
- Programs
- 5
- Drugs
- 5
- Patents
- 8
BRAINSTORM CELL THERAPEUTICS projects
2 ClinicalTrials.gov programs sponsored by BRAINSTORM CELL THERAPEUTICS.
BRAINSTORM CELL THERAPEUTICS has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does BRAINSTORM CELL THERAPEUTICS have?
2 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.